Sponsor or institution

Clinical trials and research at Larimar Therapeutics, Inc.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Nomlabofusp by injection for Friedreich's Ataxia: efficacy and safety

  This study tests whether subcutaneous nomlabofusp helps adults and children with Friedreich's Ataxia compared with placebo.

  Recruiting at 3 sites Phase 3 Larimar Therapeutics, Inc. · Tampa, Florida and 3 other locations · NCT07778836

• Long-term CTI-1601 (nomlabofusp) treatment for Friedreich's ataxia

  This trial tests daily subcutaneous CTI-1601 (nomlabofusp) in children (age 2+), adolescents, and adults with Friedreich's ataxia to see long-term safety, drug levels, biological effects, and clinical response.

  Recruiting at 7 sites Phase 2 Larimar Therapeutics, Inc. · Los Angeles, California and 9 other locations · NCT06447025

Quick answers

How many clinical trials run by Larimar Therapeutics, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →